DRKS00031175招募中Unknown
rospective, multicenter clinical study of the long-term behavior of VarseoSmile Crownplus crowns (BEGO Bremer Goldschlägerei, Bremen, Germany) in posterior teeth.
Johann Wolfgang Goethe-Universität Frankfurt am Main ZZMK Carolinum Zahnärztliches Universitäts-Institut gGmbH0 个研究点目标入组 60 人开始时间: 2023年3月13日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •In the opinion of the investigator, the patient must be reliable and cooperative and expected to comply with the study procedure.
- •Participation is on a voluntary basis with a signed declaration of consent to participate in the study.
- •There is an indication in the maxillary or mandibular posterior region for crowning the tooth. The antagonistic tooth of the tooth to be crowned is a natural tooth.
排除标准
- •Presence of alcohol or drug abuse or patient with a history of substance abuse, medication or alcohol dependence in the previous year.
- •Known unavailability of patient for follow-up.
- •Patient with clinically significant unstable medical or physiologic condition.
- •Female patient during pregnancy, during style-lens.
- •Patient with lack of consent to participate in the study or lack of understanding of the study content and purpose.
- •Uncontrolled pathological processes in the oral cavity / patient with oral infection such as untreated periodontitis or not completed periodontitis therapy.
- •Current or previous participation in a clinical trial that may affect the present study.
- •Involvement in the design and conduct of the study.
- •Known allergies to materials used.
研究者
相似试验
招募中
不适用
Multicenter prospective study evaluating the long term outcome after medical treatment for primary hepatocellular carcinomaPrimary hepatocellular carcinomaJPRN-UMIN000014806Department of Gastroenterology and Hepatology, Osaka University Graduate School of Medicine500
进行中（未招募）
1 期
A 3-year, multi-center study to describe the long term changes of optical coherence tomography (OCT) parameters in patients under treatment with Gilenya®RNFLT in Patients with relapsing remitting Multiple SclerosisMedDRA version: 18.0Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2012-000674-31-DEovartis Pharma GmbH87
进行中（未招募）
1 期
ong-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus ErythematosusSystemic Lupus ErythematosusEUCTR2018-003471-35-PLBristol-Myers Squibb International Corporation360
进行中（未招募）
1 期
ong-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus ErythematosusMedDRA version: 21.1Level: LLTClassification code 10042947Term: Systemic lupus erythematosus syndSystem Organ Class: 100000004859Systemic Lupus ErythematosusEUCTR2018-003471-35-ROBristol-Myers Squibb International Corporation360
进行中（未招募）
1 期
ong-Term Safety and Efficacy of BMS-986165 in Subjects with Systemic Lupus ErythematosusMedDRA version: 21.1Level: LLTClassification code 10042947Term: Systemic lupus erythematosus syndSystem Organ Class: 100000004859Systemic Lupus ErythematosusEUCTR2018-003471-35-HUBristol-Myers Squibb International Corporation360